Amgen (AMGN) Tops Q1 EPS by 61c; offers guidance
Tweet
Share
E-mail
Get Alerts AMGN Hot Sheet
Price: $439.33 +1.29%
Financial Fact:
Total revenues: 5.81B
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Total revenues: 5.81B
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Amgen (NASDAQ: AMGN) reported Q1 EPS of $4.90, $0.61 better than the analyst estimate of $4.29. Revenue for the quarter came in at $8.15 billion versus the consensus estimate of $8.09 billion.
GUIDANCE:
Amgen sees FY2025 EPS of $20.00-$21.20, versus the consensus of $20.63. Amgen sees FY2025 revenue of $34.3-35.7 billion, versus the consensus of $35.102 billion.
For earnings history and earnings-related data on Amgen (AMGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FTC files amicus brief challenging Amgen's Enbrel patent acquisition
- OBOOK Holdings posts $18.8M net loss as OwlPay Harbor volume rises
- loanDepot receives NYSE non-compliance notice over stock price
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
